Harry Schrager

2.3k total citations
9 papers, 549 citations indexed

About

Harry Schrager is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Harry Schrager has authored 9 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 3 papers in Epidemiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Harry Schrager's work include Streptococcal Infections and Treatments (3 papers), Antibiotic Use and Resistance (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Harry Schrager is often cited by papers focused on Streptococcal Infections and Treatments (3 papers), Antibiotic Use and Resistance (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Harry Schrager collaborates with scholars based in United States and Canada. Harry Schrager's co-authors include Michael R. Wessels, J G Rheinwald, Daniel Solomon, Katrina Curtis, Jerry Avorn, Robert J. Glynn, Laura Van Houten, G J Dougherty, Sebastián Albertí and Mary Ann Greene and has published in prestigious journals such as Journal of Clinical Investigation, Journal of the American Academy of Dermatology and Advances in experimental medicine and biology.

In The Last Decade

Harry Schrager

8 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harry Schrager United States	6	278	224	138	117	88	9	549
Oyinlola O. Oduyebo Nigeria	13	89 0.3×	204 0.9×	125 0.9×	236 2.0×	125 1.4×	60	623
Jaffu Chilongola Tanzania	16	415 1.5×	213 1.0×	177 1.3×	145 1.2×	56 0.6×	65	822
Kenneth Iregbu Nigeria	14	181 0.7×	84 0.4×	128 0.9×	277 2.4×	52 0.6×	46	579
Ajith Nagahawatte Sri Lanka	17	162 0.6×	225 1.0×	124 0.9×	174 1.5×	45 0.5×	45	587
Maha Alawi Saudi Arabia	15	100 0.4×	151 0.7×	91 0.7×	104 0.9×	33 0.4×	35	566
B. Jans Belgium	12	67 0.2×	174 0.8×	65 0.5×	165 1.4×	73 0.8×	22	536
Champica K. Bodinayake Sri Lanka	13	165 0.6×	185 0.8×	121 0.9×	125 1.1×	46 0.5×	43	442
Arjun Chandna United Kingdom	10	156 0.6×	59 0.3×	187 1.4×	148 1.3×	51 0.6×	30	515
L. Gayani Tillekeratne United States	11	91 0.3×	131 0.6×	128 0.9×	139 1.2×	52 0.6×	47	383
Ernesto Martínez Colombia	12	118 0.4×	371 1.7×	72 0.5×	137 1.2×	42 0.5×	40	619

Countries citing papers authored by Harry Schrager

Since Specialization

Citations

This map shows the geographic impact of Harry Schrager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Schrager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Schrager more than expected).

Fields of papers citing papers by Harry Schrager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Schrager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Schrager. The network helps show where Harry Schrager may publish in the future.

Co-authorship network of co-authors of Harry Schrager

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Schrager. A scholar is included among the top collaborators of Harry Schrager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Schrager. Harry Schrager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Paras, Molly L, et al.. (2024). Real-World Dalbavancin Use for Serious Gram-Positive Infections: Comparing Outcomes Between People Who Use and Do Not Use Drugs. Open Forum Infectious Diseases. 11(4). ofae186–ofae186. 9 indexed citations

2.

Paras, Molly L, et al.. (2023). 964. Real-world dalbavancin use for serious gram-positive bacterial infections: comparing outcomes between people who use and do not use drugs. Open Forum Infectious Diseases. 10(Supplement_2).

3.

Cohen, C, Amy E. Colson, Gerald Pierone, et al.. (2008). O214 The FOTO study: 24-week results support the safety of a 2-day break on efavirenz-based antiretroviral therapy. Journal of the International AIDS Society. 11(Suppl 1). O19–O19. 7 indexed citations

4.

Greene, Mary Ann, et al.. (2005). Infectious occupational exposures in dermatology–A review of risks and prevention measures. Journal of the American Academy of Dermatology. 53(6). 1020–1026. 5 indexed citations

5.

Greene, Mary Ann, et al.. (2005). Infectious occupational exposures in dermatology–A review of risks and prevention measures. Journal of the American Academy of Dermatology. 53(6). 1010–1019. 9 indexed citations

6.

Solomon, Daniel, Laura Van Houten, Robert J. Glynn, et al.. (2001). Academic Detailing to Improve Use of Broad-Spectrum Antibiotics at an Academic Medical Center. Archives of Internal Medicine. 161(15). 1897–1897. 215 indexed citations

7.

Schrager, Harry, et al.. (1998). Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes.. Journal of Clinical Investigation. 101(8). 1708–1716. 137 indexed citations

8.

Schrager, Harry & Michael R. Wessels. (1997). Hyaluronic Acid Capsule Modulates Interactions of Group A Streptococci with Human Epidermal Keratinocytes. Advances in experimental medicine and biology. 418. 517–523. 3 indexed citations

9.

Schrager, Harry, J G Rheinwald, & Michael R. Wessels. (1996). Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection.. Journal of Clinical Investigation. 98(9). 1954–1958. 164 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact